A. Labande, J.-C. Daran, E. Manoury, R. Poli
SHORT COMMUNICATION
unless otherwise stated. Mass spectra were obtained from acetoni-
trile solutions with a TSQ7000 instrument from ThermoElectron.
+ Cp), 4.52 (br. s, 1 H, Cp), 4.41 (br. s, 5 H, CpЈ), 3.81 (br. s, 1 H,
Cp), 3.52 (br. s, 3 H, CH3Im+) ppm. 13C{1H} NMR (125.8 MHz,
CDCl3, 25 °C): δ = 135.9 (NCN+), 134.0 (d, JP,C = 85.6 Hz,
1
All new compounds described were fully characterised by H, 13C,
and 31P NMR spectroscopy, elemental analysis and mass spectrom-
etry. 1,1Ј-dibromoferrocene and 1-bromo-1Ј-(diphenylphosphanyl)-
ferrocene were prepared according to literature procedures.[9]
2ϫquat. PPh2), 132.2–131.8 (m, 5ϫPPh2), 131.4 (d, JP,C =
10.1 Hz, 2ϫPPh2), 128.7 (d, JP,C = 12.6 Hz, PPh2), 128.45 (d, JP,C
= 12.6 Hz, 2ϫPPh2), 123.6 (C=C, Im+), 122.4 (C=C, Im+), 83.4
(d, JP,C = 11.3 Hz, quat. Cp), 77.5–77.0 (Cp + CDCl3), 76.3 (d, JP,C
= 11.3 Hz, Cp), 74.3 (d, JP,C = 94.4 Hz, quat. Cp), 71.4 (CpЈ), 71.3
(Cp), 48.2 (CH2Im+), 37.0 (CH3Im+) ppm. 31P{1H} NMR
(202.5 MHz, CDCl3, 25 °C): δ = 40.7 ppm. MS (ESI): m/z (%) =
497 (37) [M+], 415 (100) [M+ – C4H6N2].
General Procedures for the Preparation of Imidazolium Salts: To
a solution of 3 (100 mg, 0.23 mmol) in degassed dichloromethane
(5 mL) was quickly added HBF4 (35 µL, 54wt-% in Et2O), immedi-
ately followed by an N-substituted imidazole (0.35 mmol). The
mixture was washed with 2 aq. HCl, water, satd. aq. NaHCO3
and water again. The organic phase was dried (MgSO4), filtered
and concentrated in vacuo. Methyl-substituted salts: the residue
was taken up in dichloromethane (1 mL), diethyl ether was added
and the orange precipitate was filtered, washed with diethyl ether
and dried in vacuo to give a yellow-orange solid. Mesityl-substi-
tuted salts: the residue was purified by column chromatography on
silica gel (eluent: CH2Cl2/acetone, 9:1) to give a yellow-orange so-
lid. Similar yields were obtained starting from 500 mg of 3.
Imidazolium Salt 7b: 121 mg, 76% yield. C35H34BF4FeN2PS
(688.36): calcd. C 61.07, H 4.98, N 4.07; found C 60.34, H 4.93, N
3.98. 1H NMR (300 MHz, CDCl3, 25 °C): δ = 8.67 (s, 1 H,
NCHN+), 7.84–7.77 (m, 2 H, PPh2), 7.58–7.28 (m, 9 H, PPh2
+
HC=C Im+), 6.92 (s, 2 H, Mes), 6.71 (s, 1 H, HC=C Im+), 6.66 (d,
JH,H = 14.3 Hz, 1 H, CH2Im+), 5.58 (d, JH,H = 14.3 Hz, 1 H,
CH2Im+), 5.31 (br. s, 1 H, Cp), 4.56 (br. s, 1 H, Cp), 4.35 (s, 5 H,
CpЈ), 3.96 (br. s, 1 H, Cp), 2.30 (s, 3 H, p-CH3 Mes), 1.84 (br. s, 3
H, o-CH3 Mes), 1.68 (br. s, 3 H, o-CH3 Mes) ppm. 13C{1H} NMR
(75.5 MHz, CDCl3, 25 °C): δ = 141.2 (quat. Mes), 136.2 (NCN+),
135.0 (d, JP,C = 86.0 Hz, quat. PPh2), 134.2 (quat. Mes), 132.3 (d,
Imidazolium Salt 4a: 86 mg, 64% yield. Single crystals suitable for
X-ray diffraction studies were obtained by slow concentration of
a dichloromethane solution. C27H26BF4FeN2PS (584.21): calcd. C
55.51, H 4.49, N 4.80; found C 54.98, H 4.16, N 4.55. 1H NMR
(300 MHz, CD2Cl2, 25 °C): δ = 8.65 (s, 1 H, NCHN+), 7.79–7.72
(m, 4 H, PPh2), 7.59–7.47 (m, 6 H, PPh2), 7.29 (s, 1 H, HC=C
Im+), 7.27 (s, 1 H, HC=C Im+), 5.09 (s, 2 H, Cp), 4.69 (s, 2 H,
Cp), 4.54 (s, 2 H, Cp or CH2Im+), 4.50 (s, 2 H, Cp or CH2Im+),
4.16 (s, 2 H, Cp), 3.88 (s, 3 H, CH3Im+) ppm. 13C{1H} NMR
JP,C = 87.3 Hz, quat. PPh2), 132.0 (d, JP,C = 11.0 Hz, 2ϫPPh2
+
d, JP,C = 3.1 Hz, PPh2), 131.7 (d, JP,C = 2.9 Hz, PPh2), 131.4 (d, JP,C
= 10.5 Hz, 2ϫPPh2), 130.5 (quat. Mes), 129.7 (C-H Mes), 128.6 (d,
JP,C = 12.4 Hz, 2ϫPPh2), 128.3 (d, JP,C = 12.7 Hz, 2ϫPPh2), 122.9
(C=C Im+), 122.2 (C=C Im+), 83.6 (d, JP,C = 12.3 Hz, quat. CpC),
76.9 (d, JP,C = 8.6 Hz, Cp), 75.7 (d, JP,C = 11.4 Hz, Cp), 72.9 (d,
JP,C = 94.5 Hz, quat. CpP), 71.8 (d, JP,C = 10.1 Hz, Cp), 71.4 (CpЈ),
48.0 (CH2Im+), 21.0 (p-CH3 Mes), 17.2 (2ϫo-CH3 Mes) ppm.
31P{1H} NMR (121.5 MHz, CDCl3, 25 °C): δ = 40.4 ppm. MS
(ESI): m/z (%) = 601 (100) [M+], 415 (27) [M+ – C12H14N2], 187
(20).
(75.5 MHz, CD2Cl2, 25 °C): δ = 135.5 (NCN+), 134.2 (d, JP,C
87.0 Hz, 2ϫquat. PPh2), 131.55 (2ϫPPh2), 131.53 (d, JP,C
=
=
10.6 Hz, 4ϫPPh2), 128.4 (d, JP,C = 12.5 Hz, 4ϫPPh2), 123.6 (C=C
Im+), 121.8 (C=C Im+), 80.4 (quat. CpC), 76.2 (d, JP,C = 96.9 Hz,
quat. CpP), 74.1 (d, JP,C = 12.4 Hz, 2ϫCpP), 73.1 (d, JP,C
=
10.0 Hz, 2ϫCpP), 71.7 (2ϫCpC), 71.3 (2ϫCpC), 49.1 (CH2Im+),
36.3 (CH3Im+) ppm. 31P{1H} NMR (81.0 MHz, CD2Cl2, 25 °C): δ
Supporting Information (see footnote on the first page of this arti-
cle): Full experimental details, 1H, 13C and 31P NMR spectroscopic
data, mass spectrometric data and elemental analyses for all new
compounds. Crystal data for 4a, 7a and 9a (CCDC-616649
to -616651 contain the supplementary crystallographic data for
this paper; these data can be obtained free of charge from The
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/
datarequest/cif).
= 41.0 ppm. MS (ESI): m/z (%) = 497 (70) [M+], 415 (100) [M+
–
C4H6N2].
Imidazolium Salt 4b: 96 mg, 60% yield. C35H34BF4FeN2PS
(688.36): calcd. C 61.07, H 4.98, N 4.07; found C 60.31, H 4.71, N
3.91. 1H NMR (300 MHz, CD3CN, 25 °C): δ = 8.54 (s, 1 H,
NCHN+), 7.80–7.73 (m, 4 H, PPh2), 7.60–7.50 (m, 7 H, PPh2
+
HC=C Im+), 7.40 (s, 1 H, HC=C Im+), 7.11 (s, 2 H, Mes), 5.15
(br. s, 2 H, CH2Im+), 4.71 (br. s, 2 H, Cp), 4.55 (br. s, 2 H, Cp),
4.51 (br. s, 2 H, Cp), 4.18 (br. s, 2 H, Cp), 2.36 (s, 3 H, p-CH3
Mes), 2.00 (s, 6 H, o-CH3 Mes) ppm. 13C{1H} NMR (75.5 MHz,
CD3CN, 25 °C): δ = 141.2 (quat. Mes), 135.8 (NCN+), 134.7
(2ϫquat. Mes), 134.4 (d, JP,C = 87.0 Hz, 2ϫquat. PPh2), 131.7 (d,
JP,C = 2.9 Hz, 2ϫPPh2), 131.4 (d, JP,C = 10.7 Hz, 4ϫPPh2), 131.0
(quat. Mes), 129.5 (2ϫC-H Mes), 128.5 (d, JP,C = 12.5 Hz,
4ϫPPh2), 124.2 (C=C Im+), 122.7 (C=C Im+), 80.7 (quat. CpC),
76.1 (d, JP,C = 97.3 Hz, quat. CpP), 74.0 (d, JP,C = 12.4 Hz,
2ϫCpP), 73.2 (d, JP,C = 10.1 Hz, 2ϫCpP), 71.6 (2ϫCpC), 71.2
(2ϫCpC), 49.2 (CH2Im+), 20.2 (p-CH3 Mes), 16.6 (2ϫo-CH3 Mes)
ppm. 31P{1H} NMR (121.5 MHz, CD3CN, 25 °C): δ = 40.6 ppm.
MS (ESI): m/z (%) = 601 (100) [M+], 415 (100) [M+ – C12H14N2].
Acknowledgments
We thank the CNRS for support of this work and Yannick Coppel
for NMR analysis of the rhodium complexes.
[1] D. Bourissou, O. Guerret, F. P. Gabbai, G. Bertrand, Chem.
Rev. 2000, 100, 39.
[2] W. A. Herrmann, Angew. Chem. Int. Ed. 2002, 41, 1290–1309;
N. M. Scott, S. P. Nolan, Eur. J. Inorg. Chem. 2005, 1815–1828.
[3] N. Stylianides, A. A. Danopoulos, N. Tsoureas, J. Organomet.
Chem. 2005, 690, 5948–5958; L. D. Field, B. A. Messerle, K. Q.
Vuong, P. Turner, Organometallics 2005, 24, 4241–4250.
[4] C. Yang, H. M. Lee, S. P. Nolan, Org. Lett. 2001, 3, 1511–1514;
J. Wolf, A. Labande, J.-C. Daran, R. Poli, J. Organomet. Chem.
2006, 691, 433–443; J. Wolf, A. Labande, M. Natella, J.-C. Da-
ran, R. Poli, J. Mol. Catal. A 2006, 259, 205–212.
[5] H. Seo, H.-J. Park, B. Y. Kim, J. H. Lee, S. U. Son, Y. K.
Chung, Organometallics 2003, 22, 618–620.
[6] S. Gischig, A. Togni, Organometallics 2004, 23, 2479–2487.
[7] T. Hayashi, T. Mise, M. Fukushima, M. Kagotani, N. Nagash-
ima, Y. Hamada, A. Matsumoto, S. Kawakami, M. Konishi,
Imidazolium Salt 7a: 96 mg, 71% yield. Single crystals suitable for
X-ray diffraction studies were obtained by slow diffusion of diethyl
ether into a THF solution. C27H26BF4FeN2PS (584.21): calcd. C
55.51, H 4.49, N 4.80; found C 51.53, H 3.90, N 4.32. 1H NMR
(500 MHz, CDCl3, 25 °C): δ = 8.33 (s, 1 H, NCHN+), 7.73–7.33
(m, 10 H, PPh2), 6.98 (br. s, 1 H, HC=C Im+), 6.87 (br. s, 1 H,
HC=C Im+), 6.41 (br. s, 1 H, CH2Im+), 5.15–5.04 (m, 2 H, CH2Im+
1208
www.eurjic.org
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2007, 1205–1209